Skip to main content

Table 3 Co-morbidities

From: Optimal and continuous anaemia control in a cohort of dialysis patients in Switzerland

 

n

%

Hypertension

213

60.9

Diabetes1

96

27.4

Coronary artery disease

88

25.1

Congestive heart failure

55

15.7

Other cardiac diseases2

17

4.9

Vascular diseases3

16

4.6

Cancer (ca)4

14

4.0

Metabolic disorders5

7

2.0

Hepatological disorders6

7

2.0

Chronic obstructive pulmonary disease (COPD)

5

1.4

Hyperparathyroidism

4

1.1

Others (nephrectomy/ciclosporine nephropathy)

3

0.9

Amyloidosis

1

0.2

  1. 1 Diabetes (overall): including reported as primary diagnosis (n = 75 patients)
  2. 2 Aneurysms (2); Mitral insufficiency (3); Paroxysmal tachycardia (1); Pericarditis (1); Valvulopathy (1); Replacement of aortic valve (1) Ischemic cardiopathy (8)
  3. 3 Arteriosclerosis, arteriopathy, polyarteriovascular disease (12); Cerebrovascular disorder (3); bleeding(1);
  4. 4 Cancer: reported as concomitant diseases: prostate ca (2); ear-nose-throat ca (1); stomach ca (1); others and unknown (10)
  5. 5Obesity(3); Hypercholesterolaemia (1); Thyroiditis (1); Gout (2)
  6. 6Liver transplantation (1); Liver cirrhosis (4); Pancreatitis (2)
  7. Patients could be recorded under more than one co-morbidity.
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us